Next, check out my gal Holly’s post about the process of reintroducing foods after completing a Whole30. As she reminds us, it’s important not to just go crazy on Day 31. Instead, “[e]xperiment with foods you miss, but do it in a way that will actually help you gather more information.” The Whole30 website also has a great post on what to do when your Whole30 is finished here.
Bob is right on. The only announcement which was even worth watching was the last one because they brought back tommy Marquez and Co. the open this year was an absolute joke. I watched the first one, w high anticipation, laughed my butt off in embarrassment and didn’t watch again until 5 when I heard Marquez was back. Also, good luck w the top athletes from countries with like 10 actual crossfitters. What’s the point of bringing in an athlete who will be ousted in the first 5 min of the games while Brent Filowski sits home? Good call
You can easily turn this butter and Brain Octane Oil combo into a Whole30 recipe: Simply swap your butter for grass-fed ghee. You’ll still get all the benefits of clean coffee beans and healthy fats while sticking to the Whole30 rules. (Bonus: If you need an extra dose of protein in the morning, blend your coffee with Whole30-friendly collagen peptides.)
I personally struggle on a regular basis because I’m much more interested in heavy strength training than anything else – and I’m one of those people who really likes seeing very linear graphs and results to my training, and I do want to specialize. I have a very hard time creating workout plans because with CrossFit, you never know what’s coming next.
A diet high in phytic acid, which can be found in whole grains (it's in the bran) and beans like soy, is very detrimental for mineral absorption. Phytic acid strongly binds to minerals like calcium, iron, zinc and magnesium to form insoluble salts, phytates, which precipitate from the body and are not absorbed. Staffan Lindeberg has written a summary on phytic acid.
The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”